Crossmark

Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19

Published Online: 2024-09-13

Authors

Tran, Huong N. Q. https://orcid.org/0000-0003-3828-3862
Risk, Malcolm

Nair, Girish B.

Zhao, Lili
Funding

Funding for this research was provided by:

Foundation for the National Institutes of Health (R01AI158543)
License Information

Text and Data Mining valid from 2024-09-13

Version of Record valid from 2024-09-13
More Information

Article History

Received: 6 May 2024

Accepted: 29 August 2024

First Online: 13 September 2024

Competing interests

: The authors declare no competing interests.

Document is current